Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Clinical Data
Pharma
Lilly touts winning tirzepatide data in prediabetes patients
Lilly on Wednesday laid out full results from its longest completed study of the dual GIP/GLP-1 receptor agonist tirzepatide to date.
Fraiser Kansteiner
Nov 13, 2024 5:01pm
Amgen, AZ's Tezspire excels in phase 3 rhinosinusitis trial
Nov 8, 2024 3:31pm
Sponsored
GSK's ADC Blenrep delivers survival win against J&J's Darzalex
Nov 14, 2024 9:24am
J&J angles Darzalex for first move into early-stage myeloma
Nov 8, 2024 9:53am
Intra-Cellular's unstoppable Caplyta nails another trial
Nov 5, 2024 10:15am
Novo Nordisk's semaglutide delivers in phase 3 MASH study
Nov 1, 2024 10:38am
